The Midwest Biomedical Accelerator Consortium (MBArC) , an NIH Research Evaluation and Commercialization Hub (REACH) , a partnership led by the NIH, the University of Missouri and the University of Kansas Medical Center, is aimed at accelerating the translation of discoveries originating from academic research into products that improve health. MBArC bridges the gap between […]

The Midwest Biomedical Accelerator Consortium (MBArC) , an NIH Research Evaluation and Commercialization Hub (REACH) , a partnership led by the NIH, the University of Missouri and the University of Kansas Medical Center, is aimed at accelerating the translation of discoveries originating from academic research into products that improve health. MBArC bridges the gap between […]